NCT00206505View on ClinicalTrials.gov

Neoadjuvant Taxotere

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

Taxotere

Trial Locations (1)

77030

Baylor Breast Center, Houston

Sponsors

Collaborators (1)

Aventis Pharmaceuticals
All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Baylor Breast Care Center

OTHER